|
Volumn 5, Issue 3, 2001, Pages 250-256
|
Is quarterly cohort analysis useful for assessing treatment outcomes in a low incidence country?
a
|
Author keywords
Bacteriologically confirmed; Cohort analysis; DOTS; Pulmonary tuberculosis; Short course chemotherapy
|
Indexed keywords
ETHAMBUTOL;
ISONIAZID;
PYRAZINAMIDE;
RIFAMPICIN;
TUBERCULOSTATIC AGENT;
ARTICLE;
BACTERIOLOGY;
CLINICAL PRACTICE;
DEATH;
DRUG EFFICACY;
HEALTH PROGRAM;
HUMAN;
LUNG TUBERCULOSIS;
MAJOR CLINICAL STUDY;
MYCOBACTERIUM TUBERCULOSIS;
PRIORITY JOURNAL;
SPUTUM EXAMINATION;
TREATMENT FAILURE;
TREATMENT OUTCOME;
TUBERCULOSIS CONTROL;
WORLD HEALTH ORGANIZATION;
ADULT;
AGED;
ANTITUBERCULAR AGENTS;
COHORT STUDIES;
CZECH REPUBLIC;
HUMANS;
INCIDENCE;
MIDDLE AGED;
TIME FACTORS;
TREATMENT OUTCOME;
TUBERCULOSIS, PULMONARY;
WORLD HEALTH ORGANIZATION;
|
EID: 0035040113
PISSN: 10273719
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (15)
|
References (20)
|